Uveal melanoma (UM) is the most common primary intraocular malignancy in adults, with a
high propensity for metastasis and, historically, a lack of effective treatment options for late …

Uveal melanoma (UM) is the most common intraocular malignancy in adults. So far, no
systemic therapy or standard treatment exists to reduce the risk of metastasis and improve …

Background Uveal melanoma (UM), arising from melanocytes in the choroid, accounts for
3% to 5% of all melanocytic tumors and over 70% of intraocular malignancies. Despite …

Uveal Melanoma (UM) represents the most common primary intraocular malignant tumor in
adults. Although it originates from melanocytes as cutaneous melanoma, it shows significant …

Background Uveal melanoma (UM) is the most common primary intraocular malignancy with
a strong tendency to metastasize. The prognosis is poor once metastasis occurs. The …

Uveal melanoma is the most common intraocular malignancy although it is a rare subset of
all melanomas. Uveal melanoma has distinct biology relative to cutaneous melanoma, with …

Background Uveal melanoma (UM) is a rare and deadly eye cancer with high metastatic
potential. Despite the predominance of malignant cells within the tumor microenvironment …

Simple Summary Uveal melanoma (UM) is a rare aggressive eye cancer. Although
treatment of the eye tumour is successful, about 50% of UM patients develop a relapse of …

Background To date, no systemic therapy, including immunotherapy, exists to improve
clinical outcomes in metastatic uveal melanoma (UM) patients. To understand the role of …

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults.
Although UM and cutaneous melanoma are derived from melanocytes, UM differs clinically …